US Patent Issued to Migal Galilee Research Institute on June 30 for "Stabilized mutants of quorum quenching lactonase and use thereof in treatment of pathogens" (Israeli Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,106, issued on June 30, was assigned to Migal Galilee Research Institute Ltd. (Kiryat Shmona, Israel).

"Stabilized mutants of quorum quenching lactonase and use thereof in treatment of pathogens" was invented by Livnat Afriat-Jurnou (Kfar-Szold, Israel), Maayan Erov (Kfar Blum, Israel), David Gurevich (Manara, Israel) and Mery Dafny Yelin (Merom Golan, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Mutated phosphotriesterase-like lactonases or functional fragments can be used in methods for treating or preventing infection of a bacterium in a host, such as a plant or a part, organ or a plant propagation material. The methods include applying ...